Home > Drug Search >
  • company_query: Alder Biopharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (23) biology (16)
Status:
Approved (5) NDA Filing (1) BLA Filing (2) Phase Ⅲ (5) Phase Ⅱ (17) Phase Ⅰ (8) IND Filing (1)
Clinical Stage:
Pending (8) Active (17) Discontinued (8)
Bio-Type:
Vaccine (1) Recombinant cytokines (4) Whole antibody (7) Fusion protein (1)
Indication:
Actinic keratosis (AK) (1) Alzheimer's disease (AD) (1) Amyotrophic lateral sclerosis (ALS) (1) Anemia (1) Atherosclerosis (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Colorectal neoplasms (1) Community-acquired pneumonia (CAP) (1) Crohn's disease (2) Diabetic nephropathy (1) Follicular lymphoma (1) HBV infection (1) Heart failure (1) Hepatocellular carcinoma (HCC) (1) HIV infection (1) Malignancies (1) Melanoma (3) Migraine (2) Leucopenia (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Obesity (1) Ovarian cancer (3) Pancreatic cancer (2) Prostate cancer (2) Psoriasis (1) Psoriatic arthritis (3) Rheumatoid arthritis (RA) (7) Soft tissue infections (1) Solid tumours (6) Ulcerative colitis (1) Colorectal cancer (1) Mycoses (1) Fallopian tube cancer (1) Epithelial ovarian cancer (1) Ankylosing Spondylitis (AS) (2) Hypereosinophilic syndrome (HES) (1) Microscopic polyangiitis (1) Granulomatosis with polyangiitis (1) Spondyloarthritis (1) Susceptible bacterial infections (1) Age-related macular degeneration (AMD) (1) Bipolar disorder (1) B-cell lymphoma (1) Pediatric Crohn’s disease (1) Type 1 diabetes (1) Neutropenia (3) Renal carcinoma (2) Autoimmune diseases (1) Peritoneum cancer (1) Glioblastoma (1) Graft versus host disease (1) Plaque psoriasis (3) Diffuse large B cell lymphoma (1) Cutaneous lupus erythematosus (1) Bacterial infection (1) Liver cancer (1) hematological malignancies (1) Vertigo (1) Cachexia (1) Stomatitis (1) Juvenile idiopathic arthritis (JIA) (1)
Country:
Aprv. Year:
2008 (1) 2009 (1) 2013 (1) 2016 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top